Translational Session
Advances in Pediatric CKD and ESKD
October 25, 2024 | 02:00 PM - 04:00 PM
Location: Room 33, Convention Center
Session Description
Evidence-based treatment approaches for optimizing outcomes in pediatric patients with CKD and ESKD are lacking. This session highlights new insights gained from clinical and translational studies in children with CKD and ESKD.
Learning Objective(s)
- Identify novel biomarkers for CKD progression in children
- Summarize management options for neonatal-onset ESKD
- Discuss emerging therapies for CKD in children
Learning Pathway(s)
- Pediatric Nephrology
- Dialysis
Moderators
Presentations
- How Can Metabolomics and Lipidomics Predict Outcomes of Pediatric CKD?
02:00 PM - 02:30 PM
- Metabolic Bone Disease in Pediatric CKD: What's New?
02:30 PM - 03:00 PM
- Therapies for Neonates with Severe Early-Onset ESKD: Outcomes of the RAFT Trials
03:00 PM - 03:30 PM
- Adolescent Patients on Dialysis: How to Effectively Transition to Adult Nephrology
03:30 PM - 04:00 PM